Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome

  Free Subscription


03.10.2022

3 Aliment Pharmacol Ther
2 Clin Gastroenterol Hepatol
1 Dig Liver Dis
1 ERJ Open Res
1 Eur J Gastroenterol Hepatol
1 Eur J Obstet Gynecol Reprod Biol
1 Front Microbiol
1 Front Pharmacol
1 Front Physiol
1 Gastroenterology
1 Gut
1 J Int Med Res
1 J Virol
1 Korean J Pain
1 Med Clin North Am
2 Nat Rev Gastroenterol Hepatol
7 Neurogastroenterol Motil
1 Turk J Med Sci
1 World J Clin Cases
4 World J Gastroenterol
1 World J Gastrointest Surg
1 Zhen Ci Yan Jiu


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. ALGERA JP, Magnusson MK, Ohman L, Storsrud S, et al
    Randomised controlled trial: effects of gluten-free diet on symptoms and the gut microenvironment in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2022 Sep 29. doi: 10.1111/apt.17239.
    PubMed         Abstract available

  2. SHIN A
    Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2022;56:1300-1301.
    PubMed        

  3. FAIRBRASS KM, Hamlin PJ, Gracie DJ, Ford AC, et al
    Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease-authors' reply.
    Aliment Pharmacol Ther. 2022;56:1302-1303.
    PubMed        


    Clin Gastroenterol Hepatol

  4. MURATORE A, Shah ED, Chan WW
    Cost-Benefit Analysis of Hydrogen Breath Test-Directed Rifaximin for Treatment of Diarrhea-Predominant Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2022 Sep 21. pii: S1542-3565(22)00907.
    PubMed        

  5. BYALE A, Lennon RJ, Byale S, Breen-Lyles M, et al
    High-dimensional clustering of 4000 Irritable Bowel Syndrome Patients reveals Seven Distinct Disease Subsets.
    Clin Gastroenterol Hepatol. 2022 Sep 26. pii: S1542-3565(22)00917.
    PubMed         Abstract available


    Dig Liver Dis

  6. COSTANTINO A, Pessarelli T, Vecchiato M, Vecchi M, et al
    A practical guide to the proper prescription of physical activity in patients with irritable bowel syndrome.
    Dig Liver Dis. 2022 Sep 21. pii: S1590-8658(22)00663.
    PubMed        


    ERJ Open Res

  7. ARAI T, Inoue Y
    Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist.
    ERJ Open Res. 2022;8.
    PubMed         Abstract available


    Eur J Gastroenterol Hepatol

  8. CHENG F, Fan Z, Lin C, Zhu Y, et al
    Effect of altered gut microbiota on visceral hypersensitivity of postinfectious irritable bowel syndrome mice.
    Eur J Gastroenterol Hepatol. 2022 Sep 12. pii: 00042737-990000000-00069.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  9. SVENSSON A, Roth B, Kronvall L, Ohlsson B, et al
    TSH receptor antibodies (TRAb) - A potential new biomarker for endometriosis.
    Eur J Obstet Gynecol Reprod Biol. 2022;278:115-121.
    PubMed         Abstract available


    Front Microbiol

  10. MENG Y, Feng Y, Hang L, Zhou Y, et al
    No synergistic effect of fecal microbiota transplantation and shugan decoction in water avoidance stress-induced IBS-D rat model.
    Front Microbiol. 2022;13:995567.
    PubMed         Abstract available


    Front Pharmacol

  11. WU PN, Xiong S, Zhong P, Yang WQ, et al
    Global trends in research on irritable bowel syndrome and the brain-gut axis: Bibliometrics and visualization analysis.
    Front Pharmacol. 2022;13:956204.
    PubMed         Abstract available


    Front Physiol

  12. DONG X, Yang Y, Luo S, Deng X, et al
    Upregulation of P2X3 receptors in primary afferent pathways involves in colon-to-bladder cross-sensitization in rats.
    Front Physiol. 2022;13:920044.
    PubMed         Abstract available


    Gastroenterology

  13. CAMILLERI M, Dilmaghani S
    Treatment of Irritable Bowel Syndrome Using Fecal Microbiota Transplantation: A Step Forward?
    Gastroenterology. 2022;163:815-817.
    PubMed        


    Gut

  14. JALANKA J, Gunn D, Singh G, Krishnasamy S, et al
    Postinfective bowel dysfunction following Campylobacter enteritis is characterised by reduced microbiota diversity and impaired microbiota recovery.
    Gut. 2022 Sep 28. pii: gutjnl-2021-326828. doi: 10.1136/gutjnl-2021-326828.
    PubMed         Abstract available


    J Int Med Res

  15. HOJO M, Nagahara A
    Current perspectives on irritable bowel syndrome: a narrative review.
    J Int Med Res. 2022;50:3000605221126370.
    PubMed         Abstract available


    J Virol

  16. WENDT L, Brandt J, Ushakov DS, Bodmer BS, et al
    Evidence for Viral mRNA Export from Ebola Virus Inclusion Bodies by the Nuclear RNA Export Factor NXF1.
    J Virol. 2022;96:e0090022.
    PubMed         Abstract available


    Korean J Pain

  17. KIM N, Kim J, Yang BR, Hahm BJ, et al
    Associations of unspecified pain, idiopathic pain and COVID-19 in South Korea: a nationwide cohort study.
    Korean J Pain. 2022;35:458-467.
    PubMed         Abstract available


    Med Clin North Am

  18. POMENTI S, Devinsky J, Jodorkovsky D
    Diet for Functional Gastrointestinal Disorders/Disorders of Gut-Brain Interaction.
    Med Clin North Am. 2022;106:899-912.
    PubMed         Abstract available


    Nat Rev Gastroenterol Hepatol

  19. BRIERLEY SM, Greenwood-Van Meerveld B, Sarnelli G, Sharkey KA, et al
    Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome.
    Nat Rev Gastroenterol Hepatol. 2022 Sep 27. pii: 10.1038/s41575-022-00682.
    PubMed         Abstract available

  20. RAY K
    Bacterial histamine and abdominal pain in IBS.
    Nat Rev Gastroenterol Hepatol. 2022;19:623.
    PubMed        


    Neurogastroenterol Motil

  21. GOLLIFER RM, Taylor SA, Menys A, Zarate-Lopez N, et al
    Magnetic resonance imaging assessed enteric motility and luminal content analysis in patients with severe bloating and visible distension.
    Neurogastroenterol Motil. 2022;34:e14381.
    PubMed         Abstract available

  22. NARAYANA V, McMeans AR, Levy RL, Shulman RJ, et al
    Children with functional abdominal pain disorders successfully decrease FODMAP food intake on a low FODMAP diet with modest improvements in nutritional intake and diet quality.
    Neurogastroenterol Motil. 2022;34:e14392.
    PubMed         Abstract available

  23. BARBA E, Burri E, Quiroga S, Accarino A, et al
    Visible abdominal distension in functional gut disorders: Objective evaluation.
    Neurogastroenterol Motil. 2022 Sep 25:e14466. doi: 10.1111/nmo.14466.
    PubMed         Abstract available

  24. M H S, P E H, C F, S B, et al
    Economic living standard and abdominal pain mediate the association between functional gastrointestinal disorders and depression or anxiety.
    Neurogastroenterol Motil. 2022 Sep 25:e14465. doi: 10.1111/nmo.14465.
    PubMed         Abstract available

  25. WU J, Wang C, Lv L
    Diagnostic yield of colonoscopy for organic disease in irritable bowel syndrome and its risk factors: A meta-analysis.
    Neurogastroenterol Motil. 2022 Sep 27:e14481. doi: 10.1111/nmo.14481.
    PubMed         Abstract available

  26. GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
    Willingness to pay for medications among patients with Rome IV irritable Bowel syndrome.
    Neurogastroenterol Motil. 2022 Sep 30:e14483. doi: 10.1111/nmo.14483.
    PubMed         Abstract available

  27. GROEGER D, Murphy EF, Tan HTT, Larsen IS, et al
    Interactions between symptoms and psychological status in irritable bowel syndrome: An exploratory study of the impact of a probiotic combination.
    Neurogastroenterol Motil. 2022 Sep 30:e14477. doi: 10.1111/nmo.14477.
    PubMed         Abstract available


    Turk J Med Sci

  28. DEMIRBAS A, Elmas OF, Eker H, Demirbas GU, et al
    The relationship between hidradenitis suppurativa and irritable bowel syndrome: a cross-sectional study.
    Turk J Med Sci. 2022;52:97-104.
    PubMed         Abstract available


    World J Clin Cases

  29. NISHIDA A, Nishino K, Ohno M, Sakai K, et al
    Update on gut microbiota in gastrointestinal diseases.
    World J Clin Cases. 2022;10:7653-7664.
    PubMed         Abstract available


    World J Gastroenterol

  30. FANG XC, Fan WJ, Drossman DD, Han SM, et al
    Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
    World J Gastroenterol. 2022;28:4861-4874.
    PubMed         Abstract available

  31. QUAGLIO AEV, Grillo TG, De Oliveira ECS, Di Stasi LC, et al
    Gut microbiota, inflammatory bowel disease and colorectal cancer.
    World J Gastroenterol. 2022;28:4053-4060.
    PubMed         Abstract available

  32. MALLARET G, Lashermes A, Meleine M, Boudieu L, et al
    Involvement of toll-like receptor 5 in mouse model of colonic hypersensitivity induced by neonatal maternal separation.
    World J Gastroenterol. 2022;28:3903-3916.
    PubMed         Abstract available

  33. IKEDA Y, Taniguchi K, Sawamura H, Tsuji A, et al
    Promising role of D-amino acids in irritable bowel syndrome.
    World J Gastroenterol. 2022;28:4471-4474.
    PubMed         Abstract available


    World J Gastrointest Surg

  34. JIANG S, Song CY, Feng MX, Lu YQ, et al
    Adult patients with allied disorders of Hirschsprung's disease in emergency department: An 11-year retrospective study.
    World J Gastrointest Surg. 2022;14:656-669.
    PubMed         Abstract available


    Zhen Ci Yan Jiu

  35. LI HY, Chen Y, Hu ZY, Chen W, et al
    [Meta analysis of acupuncture and moxibustion for anxiety and depression in irritable bowel syndrome].
    Zhen Ci Yan Jiu. 2022;47:821-9.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: